Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease

Autoantibodies neutralizing the antiviral action of type I interferons (IFNs) have been associated with predisposition to severe Coronavirus Disease 2019 (COVID-19). Here, we screened for such autoantibodies in 103 critically ill COVID-19 patients in a tertiary intensive care unit (ICU) in Switzerla...

Descripción completa

Detalles Bibliográficos
Autores principales: Busnadiego, Idoia, Abela, Irene A., Frey, Pascal M., Hofmaenner, Daniel A., Scheier, Thomas C., Schuepbach, Reto A., Buehler, Philipp K., Brugger, Silvio D., Hale, Benjamin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Discovery Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286229/
https://www.ncbi.nlm.nih.gov/pubmed/35788562
http://dx.doi.org/10.1371/journal.pbio.3001709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286229/
https://www.ncbi.nlm.nih.gov/pubmed/35788562
http://dx.doi.org/10.1371/journal.pbio.3001709

Ejemplares similares